Cost-Effectiveness Analysis of Monthly Zoledronic Acid, Zoledronic Acid Every 3 Months, and Monthly Denosumab in Women With Breast Cancer and Skeletal Metastases: CALGB 70604 (Alliance)
- Citation:
- J Clin Oncol vol 35 (35) 3949-55
- Year:
- 2017
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- 7
- Parents:
- None
- Children:
- None
- Program:
- CCP
- Primary Committee:
- Symptom Inter
- Sec. Committees:
- Breast Health Outcomes
- Pharmas:
- Grants:
- UG1CA189823, U10CA180790, U10CA180838, UG1CA189819
- Corr. Author:
- Authors:
- Charles L. Shapiro James P. Moriarty Stacie Dusetzina Andrew L. Himelstein Jared C. Foster Stephen S. Grubbs Paul J. Novotny Bijan J. Borah
- Networks:
- CHRISTIANA, LAPS-MN026, LAPS-NC007, NY021
- Study
- CALGB-70604
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: